News-Medical.net The AIT Austrian Institute of Technology, BioVendor and SCIENION today announced that the three companies will partner on the development of an in-vitro diagnostic test for colon cancer. 更多 »
Proactive Investors USA & Canada Its first device, called HemoPalm, targets the point-of-care subset of the in vitro diagnostics market, and is a handheld analyzer and...
Business Wire (press release) The focus of this research report description was on various levels of analysis, industry, market shares, value chain, PESTEL analysis and company profiles which together comprise and augment about ... 更多 »
PR Newswire (press release) NEW YORK, Oct. 1, 2014 /PRNewswire/ -- Despite global economic and industry challenges, in vitro diagnostics (IVD) markets are growing robustly at double the rate of the global pharmaceutical ... 更多 »
Newswire Today (press release) Despite economic and industry challenges, the global in vitro diagnostics (IVD) market is growing robustly at double the rate of the global pharmaceutical industry. The market will remain buoyant as the ... 更多 »
SYS-CON Media (press release) LONDON, Sept. 24, 2014 /PRNewswire/ -- In vitro diagnostics are tests that diagnose and prevent diseases, conditions or infections. IVD t...
pharmabiz.com Despite economic and industry challenges, the global in vitro diagnostics (IVD) market is growing robustly – at double the rate of the global pharmaceutical industry. The market will remain buoyant as ... Report: Radical New IVD Test Approaches Key To Growth DigitalJournal.com 此专题所有 3 篇报道 »
Benzinga ERBA Diagnostics, Inc. (NYSE MKT: ERB) today announced its fully integrated portfolio of in vitro diagnostics platforms and reagents for Hematology and Clinical Chemistry are now available to ...
